Editas Medicine Competitors and Similar CompaniesClear all

Editas Medicine's competitors and similar companies include Biocytogen Boston, Amyris and Nuclera.

	Editas Medicine Editas Medicine is engaged in discovering and developing a novel class of genome editing therapeutics.	Biocytogen Boston Biocytogen Boston is a company that provides antibody drug development solutions.	Amyris Amyris is a biotechnology company that develops chemical ingredients using microbial fermentation.	Nuclera Nuclera is a company that specializes in DNA synthesis.
Founding Date	Founding Date 2013	Founding Date 2008	Founding Date 2003	Founding Date 2013
Type	Type Public	Type Subsidiary	Type Private	Type Private
Tags	Tags Healthcare bioengineering biotech genetics	Tags Healthcare biotech drug development genetics	Tags Healthcare bioengineering biotech genetics	Tags Healthcare bioengineering biotech genetics
Locations	Locations Cambridge, US HQ Boulder, US Cambridge, US	Locations Waltham, US HQ Beijing, CN Nantong, CN Shanghai, CN Heidelberg, DE San Diego, US San Francisco, US	Locations Emeryville, US HQ Sao Paulo, BR	Locations Cambridge, GB HQ
Employees	Employees 20816% increase	Employees 1833% increase	Employees 1,0031% decrease	Employees 1192% decrease
Financial
Revenue (est.)	Revenue (est.) $40.5m (FY, 2025)	Revenue (est.) N/A	Revenue (est.) $269.8m (FY, 2022)	Revenue (est.) N/A
Net income	Net income ($160.1m) (FY, 2025)	Net income N/A	Net income ($543.4m) (FY, 2022)	Net income N/A
Funding
Latest funding round	Latest funding round N/A	Latest funding round N/A	Latest funding round $ 34m (about 7 years ago)	Latest funding round $ 10m (over 7 years ago)
Total funding raised	Total funding raised $ 210m	Total funding raised $ 284.3m	Total funding raised $ 551.9m	Total funding raised $ 11.3m